Senior Director of Regulatory Policy, Strategic Development, Novo Nordisk A/S, Honorary Industrial Ambassador in Regulatory Science at the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark Merete has a very broad and deep experience in all drug development disciplines as well as heading up various therapeutic drug development projects in clinical phase I to IV. Within Regulatory, she has more than 21 years’ experience covering all regulatory disciplines in the life cycle of development projects and of products. Today Merete is very active within several EU Trade Associations (EuropaBio, EFPIA and EBE) with focus on regulatory policies and intelligence, EU advocacy within current and future regulatory challenges. “Regulatory Science is the driver for sound and more transparent regulatory decision making.” ― Merete Schmiegelow